Collaborative Drug Discovery Celebrates Five Years of Innovation
The following is a rare note from the CEO’s desk:
Congratulations CDD – now you are 5!
April 1 of 2009 commemorates the fifth year since CDD was incorporated and spun out of Eli Lilly. First and foremost, we thank our customers and the CDD community for all of their contributions that have allowed CDD to become an exciting and valuable tool for the drug discovery industry. It is gratifying to see the market confirm that CDD has addressed researchers’ real needs. We have new collaborators logging on daily and thousands of researchers consistently visiting CDD. New customers are constantly signing up – equally from both industry and academia.
With a growing user base, we have many more requests for new capabilities to keep us on target. Frankly, these include more custom requests than we can ever fulfill, but that is a healthy problem to have. And, paid services are always accommodated on time and within budget. Recently, we’ve even seen customers routinely select CDD over the established vendors in our industry. They appreciate the simplicity of using CDD to archive and mine drug discovery data, and our unique-to-the-world, secure, cost-effective collaborative capabilities.
We look forward to sharing more positive developments at our 10 year mark!